Cell Uptake, Distribution and Response to Aluminium Chloro Sulphonated Phthalocyanine, a Potential Anti-tumour Photosensitizer

Overview

Journal Br J Cancer

Specialty Oncology

Date 1986 Feb 1

PMID 2937437

Citations 17

Authors

W S Chan

R Svensen

D Phillips

I R Hart

Affiliations

Soon will be listed here.

Abstract

The uptake, retention and effects of aluminium chloro sulphonated phthalocyanine (AlSPc) were measured in two cell lines, UV-2237 a murine fibrosarcoma and the non-tumorigenic NIH/3T3 fibroblast line. The behaviour of cells treated with AlSPc was compared with that of those treated with haematoporphyrin derivative (HpD), a photosensitizer often used in photodynamic therapy (PDT) of cancer. AlSPc absorbs light strongly in the red region, is taken up by cells in a dose dependent fashion and is retained in vitro over a period of days (5 days after exposure greater than 40% remains cell-associated versus less than 25% of HpD). Additionally AlSPc was less cytotoxic to cells, maintained in darkness or exposed to room light, compared to HpD (100% viability versus 0% viability 3 days after 60 min exposure to room light). However red light (approximately 600-700 nm) caused greater toxicity in AlSPc-treated cells (100%) than in similarly exposed HpD-treated cells (less than 60%). No significant differences were detected between the responses of the fibrosarcoma and the fibroblast cell lines. These characteristics of AlSPc suggest that it may prove to be a useful photosensitizer for PDT of cancer and this possibility is discussed.

Citing Articles

Zero-Background Small-Molecule Sensors for Near-IR Fluorescent Imaging of Biomacromolecular Targets in Cells.

Mohamed M, Klenke A, Anokhin M, Amadou H, Bothwell P, Conroy B ACS Sens. 2023; 8(3):1109-1118.

PMID: 36866808 PMC: 10515643. DOI: 10.1021/acssensors.2c02342.

Experimental studies to assess the potential of photodynamic therapy for the treatment of bronchial carcinomas.

Smith S, Bedwell J, MacRobert A, Griffiths M, Bown S, Hetzel M Thorax. 1993; 48(5):474-80.

PMID: 8322231 PMC: 464496. DOI: 10.1136/thx.48.5.474.

Possible advantages of aluminum-chloro-tetrasulfonated phthalocyanine over hematoporphyrin derivative as a photosensitizer in photodynamic therapy.

Koshida K, Hisazumi H, Komatsu K, Hirata A, Uchibayashi T Urol Res. 1993; 21(4):283-8.

PMID: 8212418 DOI: 10.1007/BF00307712.

Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation.

Barr H, Tralau C, MacRobert A, Krasner N, Boulos P, Clark C Br J Cancer. 1987; 56(2):111-8.

PMID: 3663462 PMC: 2002142. DOI: 10.1038/bjc.1987.166.

Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcoma.

Tralau C, MacRobert A, Barr H, Bown S Br J Cancer. 1987; 55(4):389-95.

PMID: 3580264 PMC: 2001712. DOI: 10.1038/bjc.1987.78.

References

Kripke M, Gruys E, Fidler I . Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin. Cancer Res. 1978; 38(9):2962-7. View

Dougherty T, KAUFMAN J, Goldfarb A, Weishaupt K, Boyle D, Mittleman A . Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978; 38(8):2628-35. View

Moan J, Pettersen E, Christensen T . The mechanism of photodynamic inactivation of human cells in vitro in the presence of haematoporphyrin. Br J Cancer. 1979; 39(4):398-407. PMC: 2009925. DOI: 10.1038/bjc.1979.72. View

Dougherty T . Hematoporphyrin derivative for detection and treatment of cancer. J Surg Oncol. 1980; 15(3):209-10. DOI: 10.1002/jso.2930150303. View

Gomer C, Smith D . Photoinactivation of Chinese hamster cells by hematoporphyrin derivative and red light. Photochem Photobiol. 1980; 32(3):341-8. DOI: 10.1111/j.1751-1097.1980.tb03772.x. View

FORBES I, Cowled P, Leong A, Ward A, BLACK R, Blake A . Phototherapy of human tumours using haematoporphyrin derivative. Med J Aust. 1980; 2(9):489-93. DOI: 10.5694/j.1326-5377.1980.tb100708.x. View

Bugelski P, Porter C, Dougherty T . Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. Cancer Res. 1981; 41(11 Pt 1):4606-12. View

Kinsey J, Cortese D, Moses H, RYAN R, Branum E . Photodynamic effect of hematoporphyrin derivative as a function of optical spectrum and incident energy density. Cancer Res. 1981; 41(12 Pt 1):5020-6. View

BERENBAUM M, BONNETT R, Scourides P . In vivo biological activity of the components of haematoporphyrin derivative. Br J Cancer. 1982; 45(4):571-81. PMC: 2010978. DOI: 10.1038/bjc.1982.94. View

10.

Benson Jr R, Farrow G, Kinsey J, Cortese D, Zincke H, Utz D . Detection and localization of In situ carcinoma of the bladder with hematoporphyrin derivative. Mayo Clin Proc. 1982; 57(9):548-55. View

11.

Dahlman A, Wile A, Burns R, MASON G, Johnson F, Berns M . Laser photoradiation therapy of cancer. Cancer Res. 1983; 43(1):430-4. View

12.

Henderson B, Bellnier D, Ziring B, Dougherty T . Aspects of the cellular uptake and retention of hematoporphyrin derivative and their correlation with the biological response to PRT in vitro. Adv Exp Med Biol. 1983; 160:129-38. DOI: 10.1007/978-1-4684-4406-3_13. View

13.

Rousseau J, Autenrieth D, van Lier J . Synthesis, tissue distribution and tumor uptake of [99Tc]tetrasulfophthalocyanine. Int J Appl Radiat Isot. 1983; 34(3):571-9. DOI: 10.1016/0020-708x(83)90058-3. View

14.

Moan J, McGhie J, Jacobsen P . Photodynamic effects on cells in vitro exposed to hematoporphyrin derivative and light. Photochem Photobiol. 1983; 37(6):599-604. DOI: 10.1111/j.1751-1097.1983.tb04527.x. View

15.

Evensen J, Sommer S, Moan J, Christensen T . Tumor-localizing and photosensitizing properties of the main components of hematoporphyrin derivative. Cancer Res. 1984; 44(2):482-6. View

16.

Selman S, Klaunig J, Goldblatt P, Keck R, Britton S . Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light. Cancer Res. 1984; 44(5):1924-7. View

17.

Ha X, Sun X, Xie J, Fan X, Zhang Y, Mei Q . Clinical use of hematoporphyrin derivative in malignant tumors. Chin Med J (Engl). 1983; 96(10):754-8. View

18.

Henderson B, Waldow S, Mang T, Potter W, Malone P, Dougherty T . Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res. 1985; 45(2):572-6. View

19.

Ben-Hur E, Rosenthal I . The phthalocyanines: a new class of mammalian cells photosensitizers with a potential for cancer phototherapy. Int J Radiat Biol Relat Stud Phys Chem Med. 1985; 47(2):145-7. DOI: 10.1080/09553008514550211. View

20.

Carruth J, McKenzie A . Preliminary report of a pilot study of photoradiation therapy for the treatment of superficial malignancies of the skin, head and neck. Eur J Surg Oncol. 1985; 11(1):47-50. View